Iron status and the treatment of the anemia of prematurity

Pamela J. Kling, Joy J. Winzerling

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

Original languageEnglish (US)
Pages (from-to)283-294
Number of pages12
JournalClinics in Perinatology
Issue number2
StatePublished - 2002

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Iron status and the treatment of the anemia of prematurity'. Together they form a unique fingerprint.

Cite this